Trial Profile
A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Iguratimod or Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Iguratimod (Primary) ; Leflunomide; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Tranmod
- Sponsors Simcere Pharmaceutical Group
- 30 Oct 2014 New trial record